Paclitaxel-Induced Acute Fibrinous and Organizing Pneumonitis in Early Breast Cancer: A Case Report
Preprint
- 4 October 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Background: Paclitaxel is a chemotherapeutic drug widely used in breast cancer treatment. While common side effects are possible, paclitaxel-induced pneumonitis is rare, with an estimated incidence of 1%–5% and a high mortality rate. Case presentation: A 57-year-old Thai woman was diagnosed with stage II right breast cancer. She received adjuvant chemotherapy comprising doxorubicin and cyclophosphamide, followed by weekly paclitaxel. After the ninth paclitaxel cycle, she developed progressive dyspnea and acute respiratory failure. Empirical antibiotic therapy with meropenem, levofloxacin, oseltamivir, and trimethoprim-sulfamethoxazole was initiated to address potential bacterial/viral pneumonias and Pneumocystis carinii pneumonia. Transbronchial biopsies revealed acute fibrinous and organizing pneumonitis. The patient was placed in the prone position, and a muscle relaxant was administered. Following the administration of dexamethasone, her symptoms improved. However, while reducing the dexamethasone dosage, she developed new-onset dyspnea as well as tachy-brady arrhythmia and hypotension. Echocardiography revealed Takotsubo cardiomyopathy (stress-induced cardiomyopathy). Intravenous methylprednisolone 500 mg/day was administered for 3 days followed by transition to intravenous dexamethasone and slow tapering to prednisolone. Prednisolone was gradually tapered and eventually discontinued after 3 months. Discussion and Conclusions: Paclitaxel-induced pneumonitis is a rare complication. The diagnosis should be considered in any patient who develops respiratory symptoms while receiving paclitaxel. Acute fibrinous and organizing pneumonitis is a rare type of interstitial pneumonitis with high recurrence and mortality rates. High-dose steroids are needed to treat this type of pneumonitis.Keywords
All Related Versions
This publication has 16 references indexed in Scilit:
- Pulmonary toxicity of systemic lung cancer therapyRespirology, 2020
- Acute fibrinous and organizing pneumonia: Imaging features, pathologic correlation, and brief literature review✰Radiology Case Reports, 2018
- Clinicopathologic features associated with relapse in cryptogenic organizing pneumoniaHuman Pathology, 2014
- Mechanism of Action of Antitumor Drugs that Interact with Microtubules and TubulinCurrent Medicinal Chemistry - Anti-Cancer Agents, 2012
- Severe interstitial pneumonitis associated with the administration of taxanesJournal of Infection and Chemotherapy, 2010
- Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer and Leukemia Group B Protocol 9840Journal of Clinical Oncology, 2008
- Pulmonary Complications of Novel Antineoplastic Agents for Solid TumorsChest, 2008
- Life-threatening hypersensitivity pneumonitis induced by docetaxel (taxotere)British Journal of Cancer, 2001
- Paclitaxel-Induced Acute Bilateral PneumonitisAnnals of Pharmacotherapy, 1997
- Taxol (paclitaxel): a novel anti-microtubule agent with remarkable anti-neoplastic activityInternational Journal of Clinical and Laboratory Research, 1994